# Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care

> **NCT00703963** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 200 (actual)

## Conditions studied

- Management of Anticoagulation

## Interventions

- **DEVICE:** INRatio monitor by Hemosense
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT00703963
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703963, "Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00703963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*